Who
Michael Shetzline
SVP, CMO, Head-Res&Drug
Company insider
Files Form 4 as: SVP, CMO, Head-Res&Drug, Ironwood Pharmaceuticals.
In numbers
- Trades disclosed
- 40
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $1.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 24 Apr 2020
- Last trade
- 10 Mar 2026
- Last filed
- 12 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Mar 2026filed 12 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —136,612 at $0.00 | filing |
| 10 Mar 2026filed 12 Mar 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —136,612 at $0.00 | filing |
| 24 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $62K17,012 at $3.66 | filing |
| 24 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $62K17,012 at $3.66 | filing |
| 23 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $59K15,570 at $3.81 | filing |
| 23 Feb 2026filed 25 Feb 2026 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $59K15,570 at $3.81 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —133,333 at $0.00 | filing |
| 10 Feb 2025filed 12 Feb 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $73K41,269 at $1.76 | filing |
| 17 Jan 2025filed 22 Jan 2025 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —48,224 at $0.00 | filing |
| 20 May 2024filed 22 May 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $104K16,128 at $6.45 | filing |
| 8 Mar 2024filed 12 Mar 2024 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —34,936 at $0.00 | filing |
| 8 Mar 2024filed 12 Mar 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code M | —34,936 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —27,214 at $0.00 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $589K38,618 at $15.24 | filing |
| 12 Feb 2024filed 14 Feb 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —54,427 at $0.00 | filing |
| 17 Jan 2024filed 19 Jan 2024 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —57,971 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $104K10,324 at $10.12 | filing |
| 8 Mar 2023filed 10 Mar 2023 | IRWD Ironwood Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —34,935 at $0.00 | filing |
| 8 Mar 2023filed 10 Mar 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —69,869 at $0.00 | filing |
| 28 Feb 2023filed 1 Mar 2023 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $84K7,438 at $11.31 | filing |
News
No headline names them, or the companies they trade most, lately.